Stay Informed on the Latest Industry News & Insights Transforming the Field
Discover an exclusive selection of insights directly from our industry-leading speaker faculty.
Henry van den Bedem, Chief Technology Officer, Expedition Medicines
Take a look at our speaker interview with Henry van den Bedem, Chief Technology Officer, Expedition Medicines to hear why he is delighted to be convening with peers at the AI Convergence: Small Molecule Discovery Summit.
I’m excited to join the meeting because this community is where the next wave of clinically validated data-driven small molecules will get built. I look forward to networking with industry colleagues and to stimulating interest in investment in this broader program.
Download your copy today for an insider look at the advancements accelerating AI-enabled small molecule discovery from molecule to market.
Discover the 2026 Agenda
Catch the latest industry breakthroughs, emerging trends and exclusive insights through our dynamic roundtables and panel discussions.
Prioritize Partnering With Us
As the field rapidly expands, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.
Join Biopharma Experts
Immerse yourself in critical conversations with like-minded attendees spanning all stages of the small molecule drug discovery funnel and build invaluable connections during dedicated networking sessions.